Prot# CA183-001-012: A Phase II Study of Intravenous (IV) Vinflunine in Patients with Locally Advanced or Metastatic Transitional Cell Carcinoma (TCC) of the Urothelium

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date7/6/054/1/12

    Funding

    • PPD Development (CA183-001-012)
    • Bristol-Myers Squibb Company (CA183-001-012)